Students in the Pottsville Junior High School EAST Program are using their skills to help caregivers with loved ones who have dementia or Alzheimer's.
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
17h
Hosted on MSNMany Americans With Dementia Don't Even Know That They Have It, As They Haven't Been Officially DiagnosedIn the United States, most people with dementia don't know they have it. A new study has found that four out of five people ...
The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.
Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...
1d
Hosted on MSNCOVID-19 May Be Linked With Higher Alzheimer's Risk, Study FindsAside from the potential curse of long COVID, people who've had the SARS-CoV-2 virus may be more likely to develop high ...
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results